Caristo Diagnostics operates in the healthcare technology sector, focusing on cardiovascular diagnostic tools. The company uses technology to assist in the detection of coronary inflammation, atherosclerosis and plaque progression, which may aid in predicting cardiovascular risk and informing treatment decisions. Caristo Diagnostics serves the healthcare industry with an emphasis on preventative screening, disease diagnosis and support for drug clinical trials, intervention planning and clinical research.